Doximity, Inc. stock closed at $20.66 on 6 August after a wide, ugly candle. The daily range spanned $19.88 to $22.43 on 18.1 million shares. Sellers owned the close after price probed above $22 and gave it all back.
Summary
Key takeaways
- DOCS closed at $20.66 on 6 August, with a daily range of $19.88–$22.43 on 18.1 million shares.
- Price sits below the 20-day EMA ($21.32), the 50-day EMA ($21.64), and the 200-day EMA at $31.21.
- Doximity beat revenue expectations with sales up 7.3% YoY to $156.6 million and raised FY2027 guidance to $671M–$681M.
- Daily RSI at 44.27 signals soft momentum without oversold conditions, while MACD is effectively flat.
- The immediate decision zone sits between $20.37 and $21.35, with the daily pivot at $20.99.
Doximity, Inc. Stock Daily Structure: Bearish and Heavy
The daily bias in Doximity, Inc. stock is clearly bearish. That bias is confirmed across every major timeframe.
Notably, price closed below the 20-day EMA at $21.32 and below the 50-day EMA at $21.64. More importantly, the 200-day EMA sits far above at $31.21. That gap tells the real story of the past several months. This is a stock trading deep inside a broken longer-term trend, not one consolidating near highs.
Fundamental Headlines Meet a Weak Chart in Doximity, Inc. Stock
Doximity beat revenue expectations and raised guidance, yet the market rejected the upside. That disconnect is the central tension in Doximity, Inc. stock right now.
Sales were up 7.3% year on year to $156.6 million. Guidance for the next quarter sits near $170.5 million, close to analyst estimates. The company also signalled FY2027 revenue of $671 million to $681 million, raising its full-year guide. On the AI side, management pointed to 165 signed health system AI clients and NOHARM validation work.
However, the tape did not reward it. DOCS appeared among after-hours movers alongside high-multiple names. The daily close near the lower half of the range says enough. When a beat and a raised guide fail to hold intraday gains, the burden of proof shifts back to buyers.
Daily Momentum and Volatility in Doximity, Inc. Stock
Daily momentum in Doximity, Inc. stock is soft but not capitulating. Indicators point to a trend that has lost thrust in both directions.
Daily RSI at 44.27 sits below the midpoint without being oversold. Momentum is soft, not capitulating. MACD is effectively flat and marginally negative. The line reads -0.03 against a -0.01 signal and a -0.02 histogram. In practice, the daily trend has lost thrust in both directions. There is no clean bearish acceleration, but no reclaimed momentum either.
Bollinger Bands frame the problem. The daily midline sits at $21.41, with the upper band at $22.57 and the lower band at $20.24. Thursday’s session touched near the upper band and closed back below the midline. That is a textbook failed expansion. Meanwhile, ATR at $0.97 shows the daily volatility budget has widened materially. A dollar of average daily range on a $20 stock is not a quiet market.
Pivot levels give the working map. The daily pivot sits at $20.99, R1 at $22.10, and S1 at $19.55. Price closed below the pivot, keeping the near-term balance tilted lower. The session high overshot R1 and failed there. The low held above S1. Those two levels now define the post-earnings battlefield.
The 1H Chart: Oversold but Not Reversing
The hourly chart weakens the case for immediate follow-through selling. However, it does nothing to challenge the broader daily downtrend.
In the final hour, the 1H candle closed at $20.63 after holding a $20.32 low and pushing back to $20.80. Buyers defended the lows into the close. All three hourly EMAs sit overhead and tightly clustered. The 20-period is at $21.26, the 50-period at $21.34, and the 200-period at $21.30. That cluster forms a heavy resistance shelf between roughly $21.25 and $21.35.
Meanwhile, hourly RSI at 38.58 is the weakest reading across all three timeframes. MACD on the 1H is decisively negative. The line reads -0.19 versus a -0.06 signal and a -0.13 histogram. Short-term momentum is still expanding to the downside. Notably, price is trading below the hourly lower band at $20.56, with the midline up at $21.44. Closing outside a band is a stretched condition, not automatically a reversal signal. Still, it does raise the odds of a mean-reversion bounce toward the $21 area.
Therefore, the hourly picture complicates the bearish view without reversing it. Hourly ATR at $0.62 and pivots at $20.58, $20.84, and $20.37 define a tight, mechanical intraday range. That is a compressed structure sitting under a wall of moving averages.
15-Minute Execution Context
The 15-minute chart shows bearish pressure fading. Downside exhaustion is emerging at this timescale.
The regime is bearish, but RSI at 42.88 has recovered off the lows. MACD reads -0.22 against a -0.21 signal, leaving a histogram of just -0.01. That flattening is the first sign of downside exhaustion. Price at $20.63 trades just under the 15m 20-period EMA at $20.87. The 50-period EMA sits at $21.19 and the 200-period at $21.29.
At this scale, the Bollinger midline sits at $20.84, effectively overlapping the 20-period EMA. That confluence is the first micro-level to watch. Above it, the path opens toward the hourly EMA cluster. Below it, sellers retain control. ATR at $0.48 with pivots at $20.60, $20.83, and $20.39 keeps intraday expectations modest. Nothing here suggests a trend day is already underway.
Bullish Scenario for Doximity, Inc. Stock
A bullish reversal in Doximity, Inc. stock would need to start with a reclaim of $20.84 on the 15-minute chart. Sustained acceptance above the hourly EMA band near $21.30 would then mark a genuine shift in short-term control.
From there, the daily pivot at $20.99 and the 20-day EMA at $21.32 become the real hurdles. A daily close back above the Bollinger midline at $21.41 would neutralise the immediate bearish structure. The raised FY2027 revenue guide of $671 million to $681 million gives buyers a narrative to work with. So do the 165 signed health system AI clients, if the technical repair holds. The upside objective is the failed level at daily R1 of $22.10, then the session high at $22.43.
Bearish Scenario
The bearish case in Doximity, Inc. stock is simply the continuation of what already exists. Price remains under the daily pivot and under every major moving average.
On the downside, a break of the hourly S1 at $20.37 would expose the $20.24 daily lower band. Below that sits the post-earnings low at $19.88 and daily S1 at $19.55. A decisive loss of $19.55 would invalidate the mean-reversion thesis outright. It would confirm the earnings reaction as a distribution event rather than a shakeout.
Still, what kills the bullish case is failure at the hourly EMA cluster. If rallies stall repeatedly between $21.26 and $21.34 while hourly MACD stays negative, sellers are simply using strength to exit. Given a daily ATR near $0.97, that failure could unwind quickly.
Positioning and Risk
Doximity, Inc. stock is trading in a post-earnings discovery phase. The immediate decision zone sits between $20.37 and $21.35.
On the daily timeframe, the trend, the EMA stack and the failed upside probe argue lower. Meanwhile, the hourly oversold stretch and flattening 15m momentum argue for a bounce attempt first. Those are not contradictory conclusions, just different time horizons.
Overall, volatility is the dominant risk here. Wide daily ranges, elevated volume, and unresolved reaction to a revenue beat punish conviction held too early. Until price either reclaims the daily pivot at $20.99 or loses $19.88, the market has not chosen. Patience around those two references is the more defensible stance than anticipating the resolution.
FAQ
What is the current trend in Doximity, Inc. stock?
The daily trend remains bearish. Price sits below the 20-day EMA at $21.32, the 50-day EMA at $21.64, and the 200-day EMA at $31.21. Daily RSI at 44.27 confirms soft momentum without oversold conditions.
Did Doximity beat earnings expectations?
Yes. Revenue rose 7.3% year on year to $156.6 million, beating expectations. The company raised its FY2027 revenue guide to $671 million to $681 million and reported 165 signed health system AI clients.
What are the key levels to watch in DOCS?
The immediate decision zone is $20.37 to $21.35. Key support sits at $19.88, the post-earnings low, and $19.55, the daily S1. Resistance stands at the daily pivot of $20.99 and the 20-day EMA at $21.32.
Is DOCS oversold and due for a bounce?
The hourly chart shows oversold conditions, with price trading below the lower Bollinger band. However, this is a stretched condition, not automatically a reversal signal. A mean-reversion bounce toward $21 is possible but not yet confirmed.
Disclaimer: This article is for informational purposes only and does not constitute financial advice, an investment recommendation, or a solicitation to buy or sell any financial instrument or cryptocurrency. The analysis provided is not indicative of future results. Investing in crypto assets and financial markets carries a high risk of capital loss. Always do your own research (DYOR) and consult a qualified financial advisor before making any decision.
Article produced with the assistance of artificial intelligence and reviewed by the editorial team.
